Skip to content
Aperlena

Romania - Medicines for the nervous system - SUPPLY OF MULTIPLE SCLEROSIS MEDICINES VOL IX (SIPONIMOD, GLATIRAMER ACETATE, INTERFERON BETA 1A (30 MCG-0.5ML), INTERFERON BETA 1A (44 MCG-0.5ML))

Original România - Medicamente pentru sistemul nervos - FURNIZARE MEDICAMENTE SCLEROZA MULTIPLA VOL IX (SIPONIMOD, GLATIRAMER ACETAT, INTERFERON BETA 1A(30 MCG-0,5ML), INTERFERON BETA 1A (44MCG-0,5ML))

Open Contract notice

Key facts

Closes in
10 days
Estimated value
€10,829,433 converted from RON
Where
Romania Nord-Est
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33661000 Medicinal products for the nervous system
Original language
Romanian
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 day ago
Notice number
649861-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 19 days
  4. Awarded pending

The Aperlena Verdict

Open race

No supplier dominates: 21 different companies have won the last 22 comparable contracts from this buyer over 5 years. This is a genuinely open race.

Expected final price vs the published estimate
-95.9%

Based on 22 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.

Summary

Machine-generated summary

The contracting authority is procuring the supply of medicines for patients diagnosed with multiple sclerosis: SIPONIMOD, GLATIRAMER ACETATE, INTERFERON BETA 1A (30 mcg-0.5 ml) and INTERFERON BETA 1A (44 mcg-0.5 ml), which have been included in the National Health Programme, subprogramme for the treatment of multiple sclerosis. The framework agreement lasts 48 months. One product is an injectable solution in pre-filled syringes, 40 mg/ml, packaged as 1 ml pre-filled syringes, with a minimum framework quantity of 624 and a maximum of 93,600 units, and a minimum sub lot quantity of 12 and a maximum of 4,800. Prices may be adjusted during the framework agreement according to the reimbursement prices in the technical norms in force for the National Health Programmes, and the authority may refrain from concluding subsequent contracts if products are not needed or funds are insufficient.

Description

Achizitionarea medicamentelor SIPONIMOD, GLATIRAMER ACETAT, INTERFERON BETA 1A(30 MCG-0,5ML), INTERFERON BETA 1A (44MCG-0,5ML) in vederea asigurarii tratamentului pacientilor diagnosticati cu scleroza multipla si tinand cont ca au fost introduse in PNS, subprogramul de tratament al sclerozei multiple, conform cerintelor din caietul de sarcini atasat. Termenul de solicitare clarificari: in a 18 zi inainte de data limita de depunere a ofertelor iar termenul de raspuns la solicitarile de clarificari ale operatorilor economici: in a 11- a zi inainte de data limita de depunere a ofertelor Pe perioada derularii acordului cadru, preturile se ajusteaza in functie de preturile de decontare din Normele Tehnice in vigoare pentru Programele Nationale de Sanatate, conform formulei de mai jos: P nou = P vechi x P nou din Norme/P vechi din Norme unde: P= pret P vechi = pret adjudecat in urma licitatiei; P nou norme = pret nou din Norme valabil la data solicitarii ajustarii de pret; P vechi norme = pret vechi din Norme valabil la data initierii procedurii; Se accepta actualizarea pretului in functie de modificarile facute prin acte administrative emise de MS (ordine de pret). Autoritatea contractanta isi rezerva dreptul sa nu incheie contracte subsecvente pentru unul sau mai multe produse, in cazul in care acestea nu vor fi necesare sau resursele financiare nu o vor permite. Odata cu adresa de actualizare pret, ofertantul va transmite informatii privind pretul vechi (adjudecat), pretul nou din norme si pretul vechi din norme. Forma farmaceutica: Sol injectabila in seringa preumpluta, Concentratie/U.T.: 40mg/ml, Ambalaj: Seringi preumplute a cate 1 ml sol. inj. in seringa preumpluta; Cantitate minima AC (48 luni): 624; Cantitate maximă AC (48 luni): 93600; Cantitate minima CS (48 luni): 12; Cantitate maximă CS (48 luni): 4,800.; Forma farmaceutica: Solutie injectabila pentru administrare subcutanata; Concentratie/U.T.: 1,5 ml solutie continanad 44 mcg substanta activa/0,5 ml; Ambalaj: cartuşe din sticla cu dop cu piston din cauciuc si capac fara filet din aluminiu si cauciuc halobutilic; Cantitate minima AC (48 luni): 192; Cantitate maximă AC (48 luni): 19200; Cantitate minima CS (48 luni): 4; Cantitate maximă CS (48 luni): 1,200.; Forma farmaceutica: Comprimate filmate; Concentratie/U.T.: 0,25 mg/comprimat; Ambalaj: Comprimate filmate; Cantitate minima AC (48 luni): 120; Cantitate maximă AC (48 luni): 1200; Cantitate minima CS (48 luni): 120; Cantitate maximă CS (48 luni): 600.; Forma farmaceutica: Comprimate filmate; Concentratie/U.T.: 2 mg/comprimat; Ambalaj: Comprimate filmate; Cantitate minima AC (48 luni): 1344; Cantitate maximă AC (48 luni): 72800; Cantitate minima CS (48 luni): 28; Cantitate maximă CS (48 luni): 1,400; Forma farmaceutica: Solutie injectabila in stilou injector; Concentratie/U.T.: 30 micrograme/0,5 ml; Ambalaj: Stilou injector (PEN) de unică folosinţă continand x 0.5 ml solutie injectabila, 1 ac de injecţie şi 1 capac pentru stilou injector (PEN); Cantitate minima AC (48 luni): 4; Cantitate maximă AC (48 luni): 19200; Cantitate minima CS (48 luni): 4; Cantitate maximă CS (48 luni): 1,300.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in Romanian.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 day ago

More from this buyer

Full buyer profile

Who usually wins this buyer's contracts in this sector

Based on 22 awards with a linked company profile over the last 5 years.

What this buyer has paid before

Based on 11 comparable contracts this buyer awarded in this sector over the last 4 years.

Lower quartile
€9,205
Median award
€37,955
Upper quartile
€59,009

This tender is estimated 28432% above that median

Most recent awards

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,311,844
9,630 open across Europe right now
Buyer track record on Aperlena
64 notices tracked · 38 awarded
€2,300,111 in awarded contracts

Never miss a tender like this

311 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

10 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language